657 results Hoogste Europese rechter bevestigt dat overheden onrechtmatige staatssteun proactief moeten terugvorderen De maand maart 2019 zal vermoedelijk de juridisch handboeken ingaan als een historische maand voor het mededingings- en staatssteunrecht. Niet alleen deed het Hof van Justitie een baanbrekende uitspraak op het gebied van het verhaal van kartelschade. General Court sends Commission back to drawing board in Belgian tax rulings case The European Commission has suffered its first court defeat in a tax rulings case. The General Court recently overturned an order to recover over EUR 700 million worth of tax breaks from 55 beneficiaries. Buckle up: the ACM is racing ahead with speedy solutions and more fines The Dutch competition watchdog ACM will bite faster and fiercer, according to its new chairman Martijn Snoep. The ACM plans to shorten the length of its investigations by deciding on their merits sooner. Stibbe advises SurveyMonkey Stibbe advises SurveyMonkey on the acquisition of Usabilla for an amount of approximately $80 million. Stibbe advises KKR Stibbe advises KKR on the acquisition of Exact Software from Apax Partners. Stibbe advises PostNL Stibbe advises PostNL on the acquisition of Sandd for an enterprise value of EUR 130 million. Belgian law of 25 November 2018 on various provisions relating to the National Register The Belgian law of 25 November 2018 containing various provisions relating to the National Register and the population registers has amended the law of 8 August 1983 regulating the National Register and the use of the national identity number. Brexit and data protection: preparing for a 'no-deal' As it stands, the UK will exit the European Union at midnight on 29 March 2019. Therefore, businesses within the UK, or with trade relations with the UK, would be best advised to assume that a no-deal Brexit is inevitable. The ACM follows EU approach in its first pharmaceutical merger The Dutch Authority for Consumers and Markets (ACM) recently reviewed its first merger between two pharmaceutical companies. Digitisation and competition law: past, present and future It is nearly time for the European Commission to reveal its course of action in digitisation and competition law. The need for speed in mergers is no reason to ignore rights of defence On 16 January 2019, the European Court of Justice clarified the procedural guarantees the European Commission needs to provide to merging parties during merger reviews. Wetsvoorstel tot implementatie Vierde Spoorwegpakket op 29 januari 2019 aangenomen Eerder schreven wij een blogbericht over de implementatie van het zogenaamde 'Vierde Spoorwegpakket'. In navolging van de Tweede Kamer (9 oktober 2018) heeft de Eerste Kamer het daartoe strekkende wetsvoorstel op 29 januari 2019 aangenomen. Companies unprepared for increasing cyber risks Companies increasingly face cybercrime incidents. Stibbe offers tailor-made solutions. Sweet & Maxwell’s annual EU Competition Law Handbook The 29th edition of Sweet & Maxwell’s annual EU Competition Law Handbook has been published. European Data Protection Board provides welcoming guidance on the territorial scope of the GDPR If personal data of a Korean employee working for a U.S. company is processed in the HR department in London, does the GDPR apply? Is the GPDR applicable to a Dutch customer visiting the website of a Canadian company? Juge des cessations incompétent en cas de contournement des instances de recours spécifiques dans une législation particulière Dans son arrêt du 17 octobre 2018, la Cour d’appel de Bruxelles a fixé une limite importante à la possibilité débridée d’introduire des actions en cessation. Coups de fil mécontents = dénigrement ? L’affaire concerne le litige entre G. et son (ancien) sous-traitant, qui a éclaté lorsque G. a mis fin au contrat pour des travaux déterminés. Le sous-traitant question aurait effectivement mis fin aux travaux. Loyalty rebate scheme 'saved' by pharma company's market misconceptions The UK Competition and Markets Authority (CMA) recently closed its investigation into a discount scheme by dominant pharma company Merck Sharp & Dohme (MSD) aimed at preventing the National Health Service (NHS) from switching to competing biosimilars. Pagination Previous page Page 27 Current page 28 Page 29 Page 30 Next page
Hoogste Europese rechter bevestigt dat overheden onrechtmatige staatssteun proactief moeten terugvorderen De maand maart 2019 zal vermoedelijk de juridisch handboeken ingaan als een historische maand voor het mededingings- en staatssteunrecht. Niet alleen deed het Hof van Justitie een baanbrekende uitspraak op het gebied van het verhaal van kartelschade.
General Court sends Commission back to drawing board in Belgian tax rulings case The European Commission has suffered its first court defeat in a tax rulings case. The General Court recently overturned an order to recover over EUR 700 million worth of tax breaks from 55 beneficiaries.
Buckle up: the ACM is racing ahead with speedy solutions and more fines The Dutch competition watchdog ACM will bite faster and fiercer, according to its new chairman Martijn Snoep. The ACM plans to shorten the length of its investigations by deciding on their merits sooner.
Stibbe advises SurveyMonkey Stibbe advises SurveyMonkey on the acquisition of Usabilla for an amount of approximately $80 million.
Stibbe advises PostNL Stibbe advises PostNL on the acquisition of Sandd for an enterprise value of EUR 130 million.
Belgian law of 25 November 2018 on various provisions relating to the National Register The Belgian law of 25 November 2018 containing various provisions relating to the National Register and the population registers has amended the law of 8 August 1983 regulating the National Register and the use of the national identity number.
Brexit and data protection: preparing for a 'no-deal' As it stands, the UK will exit the European Union at midnight on 29 March 2019. Therefore, businesses within the UK, or with trade relations with the UK, would be best advised to assume that a no-deal Brexit is inevitable.
The ACM follows EU approach in its first pharmaceutical merger The Dutch Authority for Consumers and Markets (ACM) recently reviewed its first merger between two pharmaceutical companies.
Digitisation and competition law: past, present and future It is nearly time for the European Commission to reveal its course of action in digitisation and competition law.
The need for speed in mergers is no reason to ignore rights of defence On 16 January 2019, the European Court of Justice clarified the procedural guarantees the European Commission needs to provide to merging parties during merger reviews.
Wetsvoorstel tot implementatie Vierde Spoorwegpakket op 29 januari 2019 aangenomen Eerder schreven wij een blogbericht over de implementatie van het zogenaamde 'Vierde Spoorwegpakket'. In navolging van de Tweede Kamer (9 oktober 2018) heeft de Eerste Kamer het daartoe strekkende wetsvoorstel op 29 januari 2019 aangenomen.
Companies unprepared for increasing cyber risks Companies increasingly face cybercrime incidents. Stibbe offers tailor-made solutions.
Sweet & Maxwell’s annual EU Competition Law Handbook The 29th edition of Sweet & Maxwell’s annual EU Competition Law Handbook has been published.
European Data Protection Board provides welcoming guidance on the territorial scope of the GDPR If personal data of a Korean employee working for a U.S. company is processed in the HR department in London, does the GDPR apply? Is the GPDR applicable to a Dutch customer visiting the website of a Canadian company?
Juge des cessations incompétent en cas de contournement des instances de recours spécifiques dans une législation particulière Dans son arrêt du 17 octobre 2018, la Cour d’appel de Bruxelles a fixé une limite importante à la possibilité débridée d’introduire des actions en cessation.
Coups de fil mécontents = dénigrement ? L’affaire concerne le litige entre G. et son (ancien) sous-traitant, qui a éclaté lorsque G. a mis fin au contrat pour des travaux déterminés. Le sous-traitant question aurait effectivement mis fin aux travaux.
Loyalty rebate scheme 'saved' by pharma company's market misconceptions The UK Competition and Markets Authority (CMA) recently closed its investigation into a discount scheme by dominant pharma company Merck Sharp & Dohme (MSD) aimed at preventing the National Health Service (NHS) from switching to competing biosimilars.